問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Taichung Veterans General Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
Division of Rheumatology
下載
2018-12-01 - 2024-05-16
Condition/Disease
systemic lupus erythematosus (SLE)
Test Drug
VAY736 (ianalumab)、CFZ533 (iscalimab)
Participate Sites4Sites
Recruiting3Sites
未分科
2023-02-01 - 2029-04-30
Participate Sites6Sites
Not yet recruiting3Sites
2025-09-30 - 2029-12-31
xxxxxx
Recruiting4Sites
2022-11-01 - 2028-04-30
Participate Sites3Sites
2022-11-01 - 2025-04-14
Lung Diseases, Interstitial
BI 1015550
Participate Sites9Sites
Not yet recruiting8Sites
Recruiting1Sites
2011-01-01 - 2011-12-31
Terminated6Sites
2023-05-01 - 2028-10-31
Participate Sites8Sites
Recruiting5Sites
2022-01-12 - 2027-12-31
Participate Sites5Sites
Not yet recruiting5Sites
2005-05-01 - 2007-01-01
Terminated4Sites
2023-06-03 - 2026-03-09
Participate Sites2Sites
Not yet recruiting2Sites
全部
